|
Volumn 25, Issue 1, 2014, Pages 7-9
|
Unlocking new therapeutic targets and resistance mechanisms in mantle cell lymphoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATM PROTEIN;
B LYMPHOCYTE RECEPTOR;
I KAPPA B BETA;
IBRUTINIB;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
INHIBITOR OF APOPTOSIS PROTEIN 1;
INHIBITOR OF APOPTOSIS PROTEIN 2;
MAP3K14 KINASE;
PHOSPHOTRANSFERASE;
SOTRASTAURIN;
TRANSCRIPTION FACTOR RELB;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3;
UNCLASSIFIED DRUG;
ALLELE;
CANCER CELL;
CANCER RESISTANCE;
DRUG TARGETING;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
GENE MUTATION;
HUMAN;
MANTLE CELL LYMPHOMA;
PRIORITY JOURNAL;
PROTEIN PROTEIN INTERACTION;
RNA SEQUENCE;
SEQUENCE ANALYSIS;
SHORT SURVEY;
SIGNAL TRANSDUCTION;
SOMATIC MUTATION;
|
EID: 84892395662
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2013.12.011 Document Type: Short Survey |
Times cited : (16)
|
References (10)
|